APLS Q4 2019 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

APLSApellis Pharmaceuticals, Inc.

$2B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$215,858

Operating Income

-$106M

Net Income

-$113M

EPS (Diluted)

$-1.54

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$82M

Free Cash Flow

-$82M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$389M

Total Liabilities

$355M

Stockholders' Equity

$34M

Cash & Equivalents

$352M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$11,542	-100.0%
Gross Profit	-$215,858	$11,542	-1970.2%
Operating Income	-$106M	-$37M	-184.8%
Net Income	-$113M	-$36M	-210.5%